SCHEMBL9866412

SCHEMBL9866412

FC(F)(F)c1nc2ccc(Cl)cc2[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.63
▸ HPGD P15428 5/20 0.63
▸ KDM4E B2RXH2 4/20 0.63
▸ HSD17B10 Q99714 3/20 0.63
▸ MAPT P10636 3/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ HTR3E A5X5Y0 1/20 0.56
▸ HTR3B O95264 1/20 0.56
▸ HTR3A P46098 1/20 0.56
▸ BACE1 P56817 1/20 0.56
▸ HTR3D Q70Z44 1/20 0.56
▸ HTR3C Q8WXA8 1/20 0.56
▸ HTT P42858 2/20 0.56
▸ LMNA P02545 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866407 0.86 NPSR1 (0.58) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL1358510 0.84 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL10248233 0.82 ALDH1A1 (0.61) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL11720785 0.81 KDM4E (0.44) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL10694441 0.80 KDM4E (0.65) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL15330151 0.80 KDM4E (0.47) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL15330154 0.80 KDM4E (0.47) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL16042060 0.79 ALDH1A1 (0.63) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL521212 0.79 MAPT (0.97) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL1887466 0.79 ALDH1A1 (0.63) ALDH1A1HPGDKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412211-A1 Cancer therapy system THERAPEUTICAL SYSTEMS CORPORATION (US) 1991-02-13 — — EP claimed
US-4935450-A Cancer therapy system for effecting oncolysis of malignant neoplasms THERAPEUTICAL SYSTEMS CORPORATION (US) 1990-06-19 — — US claimed
CN-112209881-B Emodin oxazole compound and preparation method and application thereof 西南大学 2022-08-26 — — CN disclosed
CN-112209881-A Emodin azole alcohol compound and preparation method and application thereof 西南大学 2021-01-12 — — CN disclosed
EP-0412211-A1 Cancer therapy system THERAPEUTICAL SYSTEMS CORPORATION (US) 1991-02-13 — — EP disclosed
US-4935450-A Cancer therapy system for effecting oncolysis of malignant neoplasms THERAPEUTICAL SYSTEMS CORPORATION (US) 1990-06-19 — — US disclosed
US-4724234-A ADMINISTERING NUTRITIONAL REGIMEN AND AGENTS WHICH UNCOUPLE OXIDATIVE PHOSPHORYLATION THERAPEUTICAL SYSTEMS CORP. (US) 1988-02-09 — — US disclosed
Send feedback